The Patent Finder

Neuraxon, Inc.

Also on record
Records under this name other than patents Neuraxon, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Neuraxon, Inc.

PatentTitleStatus Expires Confidence
US 8,106,043Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity
Lapsed on the fee record
Ended Jan 31, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 31, 2024From the USPTO record
US 7,951,940Substituted indole compounds having NOS inhibitory activity
Lapsed on the fee record
Ended May 31, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 31, 2023From the USPTO record
US 8,673,909Indole compounds and methods for treating visceral pain
Lapsed on the fee record
Ended Mar 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2022From the USPTO record
US 7,375,219Substituted Indole Compounds Having Nos Inhibitory Activity
Lapsed on the fee record
Ended May 20, 2020 · High confidence
Lapsed on the fee recordEnded May 20, 2020High confidence
US 8,173,813Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity
Lapsed on the fee record
Ended May 8, 2020 · From the USPTO record
Lapsed on the fee recordEnded May 8, 2020From the USPTO record
US 6,284,794Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
Term ended
Term ended May 4, 2019 · From the USPTO record
Term endedTerm ended May 4, 2019From the USPTO record
US 8,618,286Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity
Lapsed on the fee record
Ended Dec 31, 2017 · From the USPTO record
Lapsed on the fee recordEnded Dec 31, 2017From the USPTO record
US 8,586,620Substituted indole compounds having NOS inhibitory activity
Lapsed on the fee record
Ended Nov 19, 2017 · From the USPTO record
Lapsed on the fee recordEnded Nov 19, 2017From the USPTO record
US 6,649,605Treatment of tension-type headaches with NMDA receptor antagonists
Lapsed on the fee record
Ended Nov 18, 2015 · From the USPTO record
Lapsed on the fee recordEnded Nov 18, 2015From the USPTO record
US 7,989,4471,5 and 3,6- Substituted Indole Compounds Having Nos Inhibitory Activity
Formerly held
Lapsed on the fee record
Ended Aug 2, 2015 · High confidence
Lapsed on the fee recordEnded Aug 2, 2015High confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited